JD HEALTH INTL LTD

JD HEALTH INTL LTD

8ZN · F · Healthcare / Pharmaceutical Retailers

4.65EUR-0.12 (-2.59%)

Price History

Full chart

Market Stats

Previous Close4.77
Open4.65
Day Range4.65 – 4.65
52-Week Range3.55 – 7.60
Volume0
Market Cap12.25B
P/E (TTM)15.36
Forward P/E15.58
EPS0.25
Dividend Yield0.00%
Beta1.18
50-Day Avg4.08
200-Day Avg4.98

About

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions. In addition, it provides online marketing services to advertisers; and online shopping and hospital services. Further, the company offers smart monitoring and respiratory therapy devices; senior-oriented medical devices; home medical device set-up and support services, including blood glucose meters and oxygen generators; and rapid testing products. Additionally, it provides traditional Chinese medicine (TCM) wellness and professional orthopedic services, as well as operates offline examination and polyclinic centers that offers convenient and professional healthcare services. The company offers pharmaceutical and healthcare products through direct sales, and online marketplace and on-demand retail businesses. It serves pharmaceutical and healthcare product companies. JD Health International Inc. was founded in 2014 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMr. Cao Dong
  • Employees6.02K
  • HeadquartersJingdong Headquarters, Beijing, China, 101111, Germany
  • Websitehttps://ir.jdhealth.com

Leadership

  • Mr. Cao DongCEO & Director · b. 1977
  • Ms. Deng HuiChief Financial Officer · b. 1987
  • Mr. Ming King Chiu FCIS, FCSCompany Secretary · b. 1977

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue10.84B19.38B30.68B46.74B53.53B58.16B73.44B
Growth (%)-+78.77%+58.30%+52.32%+14.54%+8.65%+26.28%
Cost of Revenue8.03B14.47B23.48B36.84B41.66B44.85B55.24B
Gross Profit2.81B4.92B7.20B9.89B11.87B13.31B18.20B
Gross Margin25.94%25.37%23.46%21.16%22.17%22.88%24.78%
Operating Expense2.38B4.57B8.56B9.94B11.16B11.83B14.26B
Operating Income433.44M351.71M-1.37B-46.92M700.71M1.48B3.94B
Operating Margin4.00%1.81%-4.45%-0.10%1.31%2.54%5.37%
EBITDA---845.58M2.93B5.02B6.32B
EBITDA Margin---1.81%5.47%8.63%8.61%
Net Income-971.80M-17.23B-1.07B380.11M2.14B4.16B5.38B
Net Income Margin-8.96%-88.92%-3.50%0.81%4.00%7.16%7.32%
R&D338.24M609.07M892.91M1.07B1.23B1.33B1.63B
R&D as % of Total Revenue3.12%3.14%2.91%2.28%2.29%2.29%2.22%
Interest Expense35.50M3.42M6.00M9.10M9.48M8.19M11.10M
Interest Expense % of Total Revenue0.33%0.02%0.02%0.02%0.02%0.01%0.02%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets8.68B43.99B48.00B61.28B64.29B71.27B81.59B
Total Liabilities9.14B4.74B8.15B16.49B14.92B16.03B21.51B
Total Equity-459.03M39.25B39.85B44.78B49.36B55.23B60.07B
Cash4.97B32.27B17.25B18.72B15.04B22.63B31.78B

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow409.47M3.70B3.43B5.91B4.60B4.33B10.17B
Investing Cash Flow-1.45B-7.84B-17.75B----
Financing Cash Flow6.51B32.03B-163.65M----
Capital Expenditure5.19M15.70M502.21M40.16M69.33M46.35M151.01M
Free Cash Flow403.78M3.66B2.91B3.63B4.54B4.29B10.02B
FCF to OCF98.61%98.95%84.90%61.51%98.49%98.93%98.52%

Earnings

Report DateMar 4, 2027
EPS Estimate-
EPS Actual-
Surprise-
TimingAfter-hours

Key Statistics & Ratios

Market Cap12.25B
Enterprise Value6.47B
Trailing P/E15.36
Forward P/E15.58
PEG Ratio1.41
Price / Sales0.15
Price / Book1.57
EPS0.25
Book Value2.54
Revenue (TTM)79.04B
Gross Profit (TTM)19.99B
EBITDA5.09B
Profit Margin7.86%
Operating Margin7.77%
Return on Equity10.40%
Return on Assets3.73%
Shares Outstanding3.19B
Shares Float1.01B
Beta1.18
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%